Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
5.17
+0.44 (9.30%)
At close: Apr 1, 2026, 4:00 PM EDT
5.23
+0.06 (1.16%)
After-hours: Apr 1, 2026, 7:46 PM EDT

Atara Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4213278553151,445
Market Cap Growth
2.87%69.90%42.86%-82.65%-78.22%-11.72%
Enterprise Value
44.17133.3665.448.55129.891,099
Last Close Price
5.1718.0913.3112.8282.00394.00
PE Ratio
2.017.04-1.17-0.20-1.46-4.34
Forward PE
-19.88----
PS Ratio
0.351.100.606.374.9571.03
PB Ratio
--3.44-0.80-0.552.485.17
P/TBV Ratio
-1.71-5.97-1.02-0.552.645.28
P/FCF Ratio
--2.60-1.13-0.28-1.15-6.25
P/OCF Ratio
--2.60-1.13-0.28-1.16-6.55
EV/Sales Ratio
0.371.100.515.662.0454.04
EV/EBITDA Ratio
0.863.51-0.83-0.18-0.47-3.32
EV/EBIT Ratio
0.893.72-0.78-0.18-0.46-3.23
EV/FCF Ratio
--2.62-0.95-0.25-0.47-4.76
Debt / Equity Ratio
-0.24-0.24-0.31-0.460.460.09
Debt / EBITDA Ratio
0.250.25-0.38-0.17-0.21-0.08
Debt / FCF Ratio
-0.18-0.18-0.43-0.23-0.21-0.11
Net Debt / Equity Ratio
-0.02-0.020.130.06-1.46-1.24
Net Debt / EBITDA Ratio
0.020.020.160.020.671.04
Net Debt / FCF Ratio
-0.02-0.020.180.030.671.50
Asset Turnover
1.871.870.940.030.150.04
Inventory Turnover
3.983.982.061.570-
Quick Ratio
0.650.650.330.603.593.52
Current Ratio
0.820.820.480.723.743.64
Return on Equity (ROE)
-48.15%-48.15%86.92%-2014.86%-112.39%-91.69%
Return on Assets (ROA)
55.40%55.40%-60.76%-101.87%-66.43%-64.48%
Return on Invested Capital (ROIC)
123.68%123.68%-129.47%-333.98%-448.24%-799.67%
Return on Capital Employed (ROCE)
-355.72%-355.72%7592.17%-172.08%-85.02%-78.49%
Earnings Yield
77.31%14.21%-85.73%-508.50%-68.29%-23.03%
FCF Yield
-120.48%-38.45%-88.43%-355.77%-87.28%-16.00%
Buyback Yield / Dilution
-69.84%-69.85%-76.77%-3.83%-8.88%-26.63%
Total Shareholder Return
-69.84%-69.85%-76.77%-3.83%-8.88%-26.63%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q